Add Company
Join Now

OvaScience Revenue and Competitors

License our Company Data API

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • OvaScience's estimated annual revenue is currently $1.9M per year.(i)
  • OvaScience's estimated revenue per employee is $155,000

Employee Data

  • OvaScience has 12 Employees.(i)
  • OvaScience grew their employee count by -33% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is OvaScience?

OvaScience, Inc. (NASDAQ:OVAS) is a company focused on the discovery and development of new treatment options for women and families struggling with infertility. Each OvaScience treatment is based on the Company’s proprietary technology platform that leverages the breakthrough discovery of EggPC cells – immature egg cells found within the outer ovarian cortex. OvaScience is developing OvaPrime, a potential fertility treatment that could help restore a woman’s egg production, and OvaTure, a potential fertility treatment that eliminates the need for hormone stimulation. OvaScience’s AUGMENT treatment, designed to improve fertilization and pregnancy rates, is available in Japan under an exclusive license to IVF Japan. OvaScience treatments are not available in the United States. For more information, visit www.ovascience.com.

keywords:N/A

N/A

Total Funding

12

Number of Employees

$1.9M

Revenue (est)

-33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.6M12N/AN/A
#2
$1.9M1233%N/A
#3
$1.6M12-14%N/A
#4
$1.6M12-14%N/A
#5
$1M12-74%N/A